{"id":54225,"date":"2023-02-24T13:07:48","date_gmt":"2023-02-24T12:07:48","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/castle-biosciences-chief-financial-officer-frank-stokes-selected-among-the-top-25-cfos-of-houston-for-2023-by-finance-investing\/"},"modified":"2023-02-24T13:07:48","modified_gmt":"2023-02-24T12:07:48","slug":"castle-biosciences-chief-financial-officer-frank-stokes-selected-among-the-top-25-cfos-of-houston-for-2023-by-finance-investing","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/castle-biosciences-chief-financial-officer-frank-stokes-selected-among-the-top-25-cfos-of-houston-for-2023-by-finance-investing\/","title":{"rendered":"Castle Biosciences\u2019 Chief Financial Officer Frank Stokes Selected Among the Top 25 CFOs of Houston for 2023 by Finance & Investing"},"content":{"rendered":"
\n

FRIENDSWOOD, Texas–(BUSINESS WIRE)–$CSTL<\/a> #CSTL<\/a>–Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its chief financial officer, Frank Stokes, was named to Finance & Investing\u2019s Top 25 CFOs of Houston list for 2023. This year\u2019s awardees are financial executives at the forefront of the rapid technological development occurring throughout Houston across key global industries, including energy, life sciences, manufacturing, logistics and aerospace.\n<\/p>\n

<\/a><\/p>\n

\n\u201cI am proud of Frank\u2019s accomplishments at Castle,\u201d said Derek Maetzold, president and chief executive officer of Castle Biosciences. \u201cWe believe his recognition among Houston\u2019s Top 25 CFOs is a testament to his financial acuity and keen business acumen, which have been an asset to our organization and supported our financial and operational growth.\u201d\n<\/p>\n

\nHaving served as Castle\u2019s chief financial officer since December 2017, Stokes was instrumental in the Company\u2019s initial public offering in 2019 and the Company\u2019s acquisitions of Cernostics, Inc. and its TissueCypher\u00ae Barrett\u2019s Esophagus test in 2021, and AltheaDx, Inc. and its IDgenetix\u00ae test for mental health conditions in 2022. Prior to joining Castle, Stokes served as chief financial officer for Hammock Pharmaceuticals, and as a managing director of Leerink Swann (now SVB Leerink), Robert W. Baird & Co. Incorporated and Wachovia Securities, LLC. Stokes holds a B.S. degree in business administration and J.D. and MBA degrees from the University of North Carolina at Chapel Hill.\n<\/p>\n

\nThe full list of Finance & Investing\u2019s Top 25 CFOs of Houston for 2023 can be viewed here<\/a>.\n<\/p>\n

\nAbout Castle Biosciences<\/b>\n<\/p>\n

\nCastle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform disease management by keeping people first: patients, clinicians, employees and investors.\n<\/p>\n

\nCastle\u2019s current portfolio consists of tests for skin cancers, uveal melanoma, Barrett\u2019s esophagus and mental health conditions. Additionally, the Company has active research and development programs for tests in other diseases with high clinical need, including its test in development to predict systemic therapy response in patients with moderate-to-severe psoriasis, atopic dermatitis and related conditions. To learn more, please visit www.CastleBiosciences.com<\/a> and connect with us on LinkedIn<\/a>, Facebook<\/a>, Twitter<\/a> and Instagram<\/a>.\n<\/p>\n

\nDecisionDx-Melanoma, DecisionDx-CMSeq<\/i>, DecisionDx-SCC, MyPath Melanoma, DiffDx-Melanoma, DecisionDx-UM, DecisionDx-PRAME, DecisionDx-UMSeq<\/i>, TissueCypher and IDgenetix are trademarks of Castle Biosciences, Inc.\n<\/p>\n

\nAbout Finance & Investing<\/b>\n<\/p>\n

\nFinance & Investing is a comprehensive source for research and information, business news and corporate actions related to investment banking, wealth management and the public and private markets. The firm is run by a seasoned team of editors, writers and media professionals highly knowledgeable on finance and investing and the various firms and executives that make up the sector. Finance & Investing and its affiliates circulate its content to over 38,000 individuals and businesses.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor Contact:<\/b>
Camilla Zuckero
\n
czuckero@castlebiosciences.com<\/a>\n<\/p>\n

\nMedia Contact:<\/b>
Allison Marshall
\n
amarshall@castlebiosciences.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

FRIENDSWOOD, Texas–(BUSINESS WIRE)–$CSTL #CSTL–Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its chief financial officer, Frank Stokes, was named to Finance & Investing\u2019s Top 25 CFOs of Houston list for 2023. This year\u2019s awardees are financial executives at the forefront of the rapid technological … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-54225","6":"format-standard","7":"category-industry"},"yoast_head":"\nCastle Biosciences\u2019 Chief Financial Officer Frank Stokes Selected Among the Top 25 CFOs of Houston for 2023 by Finance & Investing - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/castle-biosciences-chief-financial-officer-frank-stokes-selected-among-the-top-25-cfos-of-houston-for-2023-by-finance-investing\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Castle Biosciences\u2019 Chief Financial Officer Frank Stokes Selected Among the Top 25 CFOs of Houston for 2023 by Finance & Investing - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"FRIENDSWOOD, Texas–(BUSINESS WIRE)–$CSTL #CSTL–Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its chief financial officer, Frank Stokes, was named to Finance & Investing\u2019s Top 25 CFOs of Houston list for 2023. This year\u2019s awardees are financial executives at the forefront of the rapid technological ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/castle-biosciences-chief-financial-officer-frank-stokes-selected-among-the-top-25-cfos-of-houston-for-2023-by-finance-investing\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-24T12:07:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230224005015\/en\/1721653\/21\/CastleLogo2Color.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/castle-biosciences-chief-financial-officer-frank-stokes-selected-among-the-top-25-cfos-of-houston-for-2023-by-finance-investing\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/castle-biosciences-chief-financial-officer-frank-stokes-selected-among-the-top-25-cfos-of-houston-for-2023-by-finance-investing\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Castle Biosciences\u2019 Chief Financial Officer Frank Stokes Selected Among the Top 25 CFOs of Houston for 2023 by Finance & Investing\",\"datePublished\":\"2023-02-24T12:07:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/castle-biosciences-chief-financial-officer-frank-stokes-selected-among-the-top-25-cfos-of-houston-for-2023-by-finance-investing\\\/\"},\"wordCount\":494,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/castle-biosciences-chief-financial-officer-frank-stokes-selected-among-the-top-25-cfos-of-houston-for-2023-by-finance-investing\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230224005015\\\/en\\\/1721653\\\/21\\\/CastleLogo2Color.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/castle-biosciences-chief-financial-officer-frank-stokes-selected-among-the-top-25-cfos-of-houston-for-2023-by-finance-investing\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/castle-biosciences-chief-financial-officer-frank-stokes-selected-among-the-top-25-cfos-of-houston-for-2023-by-finance-investing\\\/\",\"name\":\"Castle Biosciences\u2019 Chief Financial Officer Frank Stokes Selected Among the Top 25 CFOs of Houston for 2023 by Finance & Investing - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/castle-biosciences-chief-financial-officer-frank-stokes-selected-among-the-top-25-cfos-of-houston-for-2023-by-finance-investing\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/castle-biosciences-chief-financial-officer-frank-stokes-selected-among-the-top-25-cfos-of-houston-for-2023-by-finance-investing\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230224005015\\\/en\\\/1721653\\\/21\\\/CastleLogo2Color.jpg\",\"datePublished\":\"2023-02-24T12:07:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/castle-biosciences-chief-financial-officer-frank-stokes-selected-among-the-top-25-cfos-of-houston-for-2023-by-finance-investing\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/castle-biosciences-chief-financial-officer-frank-stokes-selected-among-the-top-25-cfos-of-houston-for-2023-by-finance-investing\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/castle-biosciences-chief-financial-officer-frank-stokes-selected-among-the-top-25-cfos-of-houston-for-2023-by-finance-investing\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230224005015\\\/en\\\/1721653\\\/21\\\/CastleLogo2Color.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230224005015\\\/en\\\/1721653\\\/21\\\/CastleLogo2Color.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/castle-biosciences-chief-financial-officer-frank-stokes-selected-among-the-top-25-cfos-of-houston-for-2023-by-finance-investing\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Castle Biosciences\u2019 Chief Financial Officer Frank Stokes Selected Among the Top 25 CFOs of Houston for 2023 by Finance & Investing\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Castle Biosciences\u2019 Chief Financial Officer Frank Stokes Selected Among the Top 25 CFOs of Houston for 2023 by Finance & Investing - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/castle-biosciences-chief-financial-officer-frank-stokes-selected-among-the-top-25-cfos-of-houston-for-2023-by-finance-investing\/","og_locale":"en_US","og_type":"article","og_title":"Castle Biosciences\u2019 Chief Financial Officer Frank Stokes Selected Among the Top 25 CFOs of Houston for 2023 by Finance & Investing - Pharma Trend","og_description":"FRIENDSWOOD, Texas–(BUSINESS WIRE)–$CSTL #CSTL–Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its chief financial officer, Frank Stokes, was named to Finance & Investing\u2019s Top 25 CFOs of Houston list for 2023. This year\u2019s awardees are financial executives at the forefront of the rapid technological ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/castle-biosciences-chief-financial-officer-frank-stokes-selected-among-the-top-25-cfos-of-houston-for-2023-by-finance-investing\/","og_site_name":"Pharma Trend","article_published_time":"2023-02-24T12:07:48+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230224005015\/en\/1721653\/21\/CastleLogo2Color.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/castle-biosciences-chief-financial-officer-frank-stokes-selected-among-the-top-25-cfos-of-houston-for-2023-by-finance-investing\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/castle-biosciences-chief-financial-officer-frank-stokes-selected-among-the-top-25-cfos-of-houston-for-2023-by-finance-investing\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Castle Biosciences\u2019 Chief Financial Officer Frank Stokes Selected Among the Top 25 CFOs of Houston for 2023 by Finance & Investing","datePublished":"2023-02-24T12:07:48+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/castle-biosciences-chief-financial-officer-frank-stokes-selected-among-the-top-25-cfos-of-houston-for-2023-by-finance-investing\/"},"wordCount":494,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/castle-biosciences-chief-financial-officer-frank-stokes-selected-among-the-top-25-cfos-of-houston-for-2023-by-finance-investing\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230224005015\/en\/1721653\/21\/CastleLogo2Color.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/castle-biosciences-chief-financial-officer-frank-stokes-selected-among-the-top-25-cfos-of-houston-for-2023-by-finance-investing\/","url":"https:\/\/pharma-trend.com\/en\/castle-biosciences-chief-financial-officer-frank-stokes-selected-among-the-top-25-cfos-of-houston-for-2023-by-finance-investing\/","name":"Castle Biosciences\u2019 Chief Financial Officer Frank Stokes Selected Among the Top 25 CFOs of Houston for 2023 by Finance & Investing - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/castle-biosciences-chief-financial-officer-frank-stokes-selected-among-the-top-25-cfos-of-houston-for-2023-by-finance-investing\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/castle-biosciences-chief-financial-officer-frank-stokes-selected-among-the-top-25-cfos-of-houston-for-2023-by-finance-investing\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230224005015\/en\/1721653\/21\/CastleLogo2Color.jpg","datePublished":"2023-02-24T12:07:48+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/castle-biosciences-chief-financial-officer-frank-stokes-selected-among-the-top-25-cfos-of-houston-for-2023-by-finance-investing\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/castle-biosciences-chief-financial-officer-frank-stokes-selected-among-the-top-25-cfos-of-houston-for-2023-by-finance-investing\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/castle-biosciences-chief-financial-officer-frank-stokes-selected-among-the-top-25-cfos-of-houston-for-2023-by-finance-investing\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230224005015\/en\/1721653\/21\/CastleLogo2Color.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230224005015\/en\/1721653\/21\/CastleLogo2Color.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/castle-biosciences-chief-financial-officer-frank-stokes-selected-among-the-top-25-cfos-of-houston-for-2023-by-finance-investing\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Castle Biosciences\u2019 Chief Financial Officer Frank Stokes Selected Among the Top 25 CFOs of Houston for 2023 by Finance & Investing"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54225","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=54225"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54225\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=54225"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=54225"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=54225"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}